Oversold

ORMP

Valuation59/ 100
Cash flow & growth37/ 100
Upside potential39/ 100
Risk potential37/ 100

ORMP's valuation appears fair, below average fundamentals limit its appeal and weaker than expected earnings are holding it back, though analyst coverage is limited.

Score change since last week

The score rose 3 points, mainly due to valuation and price changes. Price fell 0.4%, from $5.03 to $5.01. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 2.8 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 1.2× versus the full-history median of 4.3× shown in the valuation table, producing 62.2/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 58.5/100. The model applies a -47.7% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 3.2× (18-month half-life). A reliable earnings-based price target is unavailable. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are weak. Over the past year: revenue -100%. The business score is 36.5/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Weaker business results limit upside support. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 23.4% upside, or about $6.18.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Historical price swings are the main risk driver, even without a sharp profit decline.

The stock’s historical price swings drive this figure. Price history and operating stress provide the reference because comparable earnings do not support a future PE target. Operating stress reflects revenue, earnings, margins, outlook and relevant debt exposure. The larger stress gives 36.9% downside, or about $3.16, with a 15% minimum.

This is a scenario based on our model, not a forecast or probability.

ORMP vs Historical averages

MetricCurrentAverageRelative
PE1.2x8.2x85% lower
PE percentile2.15196% lower
EPS$4.11-$0.23$4.34 higher
FCF-$5.4M-$14.3M+$8.9M
Loading historical comparisons…

ORMP’s earnings are above their historical averages, while its earnings multiple is lower.

ORMP Forward outlook

MetricOutlook
Forward valuationStrongly deteriorating
Forward earningsStrong decline
Forward revenue--
Forward profitability--
Analyst coverageLimited
Estimate dispersionTight

ORMP’s available outlook is weakening, with weaker expected earnings weighing on the picture.

ORMP PE Valuation

Loading pe valuation table…

This table applies ORMP's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

ORMP Earnings Per Share

Loading earnings per share…

This chart tracks ORMP's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

ORMP Quarterly Revenue

Loading quarterly revenue…

This chart tracks ORMP's quarterly revenue over time and shows how sales are changing from year to year.

ORMP Free Cash Flow

Loading free cash flow…

This chart tracks ORMP's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

ORMP Total Shares

Loading shares over time…

This chart tracks changes in ORMP's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

ORMP Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

ORMP PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares ORMP's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

ORMP Weekly Price

Loading weekly price…

This chart uses ORMP's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

ORMP Weekly Moving Averages

Loading weekly moving averages…

This chart compares ORMP's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

ORMP Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.